Heart Transplantation Clinical Trials

Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan®) Therapy in Cardiac Transplantation
PI: Sean Pinney, MD & Peter Heeger, MD
IRB Approval Pending

Observational Study of Alloimmunity in Cardiac Transplant Recipients
PI: Sean Pinney, MD & Peter Heeger, MD
Active, Enrollment Closed

A 24-month, multi-center, randomized, open-label, non-inferiority study of efficacy and safety comparing two exposures of concentration-controlled Certican with reduced Neoral versus 3.0 g MMF with standard dose Neoral in de novo heart transplant recipients
PI: Sean Pinney, MD
Active, Enrollment Closed